Jon Glass - Concepedia

Author

Jon Glass

Thomas Jefferson University

Also Known As

J D Glass, J GLASS, J Glass, J. D. Glass, J. Glass, Jon Glass, Nick Vallotton

135

Publications

7.3K

Citations

H-Index

Concepts

All Affiliations

Thomas Jefferson University Neurological Surgery Sidney Kimmel Cancer Center University of Edinburgh Massachusetts General Hospital

About

Jon Glass is an author at Thomas Jefferson University specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	2.4K
2	Health Sciences	11	12	511
3	Engineering	2	2	190
4	Social Sciences	1	1	12
5	Anesthesia	1	1	27

Jon Glass

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, Cancer Discovery	2017	390
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas Shannon Fogh, David W. Andrews, Jon Glass, Journal of Clinical Oncology	2010	342
Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome Jon Glass, Michael L. Gruber, Lawrence Cher, Journal of neurosurgery	1994	341
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Intravascular lymphomatosis a systemic disease with neurologic manifestations Jon Glass, Fred H. Hochberg, Douglas C. Miller Cancer	1993	251
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme Colin E. Champ, Joshua D. Palmer, Jeff S. Volek, Journal of Neuro-Oncology Neuro-oncologyKetogenic DietChemoprevention StrategyGlioblastoma MultiformeMedicine	2014	216
Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial Philip M. Bath, Polly Scutt, Craig S. Anderson, The Lancet	2019	192

Page 1